Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

Data Compilation
#PharmaFlow

Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

Stock Recap
#PipelineProspector

Dibasic potassium phosphate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

27 API Suppliers, 14 USDMF, 1 CEP/COS, 8 NDC API, 13 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

FINISHED DOSAGE FORMULATIONS

113 FDF Dossiers, 76 FDA Orange Book, 23 Europe, 13 Canada, 1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - 1.18GM/100ML (11.8MG/ML);1.12GM/100ML (11.2MG/ML), SOLUTION;INTRAVENOUS - 1.18GM/5ML (236MG/ML);1.12GM/5ML (224MG/ML), SOLUTION;INTRAVENOUS - 1.18GM/250ML (4.72MG/ML);1.12GM/250ML (4.48MG/ML), SOLUTION;INTRAVENOUS - 11.8GM/50ML (236MG/ML);11.2GM/50ML (224MG/ML), SOLUTION;INTRAVENOUS - 3.54GM/15ML (236MG/ML);3.36GM/15ML (224MG/ML)

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Evonik, 7 Rochem International Inc, 19 SPI Pharma, 6 DKSH, 4 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 3 Pfanstiehl, 13 Kirsch Pharma, 1 ACG Worldwide, 15 Actylis, 1 Aeon Procare, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 1 Avesta Pharma, 28 BASF, 1 Bioplus Life Sciences, 3 CD Formulation, 2 Clariant, 10 Corel Pharma Chem, 6 DFE Pharma, 2 Esteem Industries, 3 Finar, 9 Gangwal Chemicals, 4 Ideal Cures, 5 Ingredion Pharma Solutions, 20 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 17 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 10 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 39 Roquette, 8 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 1 Symrise, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 4 Vasa Pharmachem, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

85 Fillers, Diluents & Binders, 46 Coating Systems & Additives, 39 Thickeners and Stabilizers, 37 Parenteral, 33 Direct Compression, 32 Topical, 31 Taste Masking, 31 Disintegrants & Superdisintegrants, 29 Granulation, 25 Controlled & Modified Release, 24 Solubilizers, 21 Chewable & Orodispersible Aids, 20 Lubricants & Glidants, 18 Film Formers & Plasticizers, 14 Co-Processed Excipients, 10 Emulsifying Agents, 7 API Stability Enhancers, 6 Rheology Modifiers, 5 Empty Capsules, 4 Coloring Agents, 4 Vegetarian Capsules, 3 Surfactant & Foaming Agents, 1 Soft Gelatin

DIGITAL CONTENT

3 Data Compilation #PharmaFlow, 13 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 15 Regulatory FDF Prices

MARKET PLACE

6 APIs

6 APIs

PATENTS & EXCLUSIVITIES

5 US Patents

5 US Patents

REF. STANDARDS & IMPURITIES

3 Others

3 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
29/11/2025	Merck Group	Germany	Merck KGaA Darmstadt DE	R1-CEP 2014-307 - Rev 00	Dipotassium phosphate	2020-12-10	Valid	Chemical		1003

Dibasic Potassium Phosphate

Dibasic potassium phosphate

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

27 API Suppliers

14 USDMF

1 CEP/COS

8 NDC API

13 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

FINISHED DOSAGE FORMULATIONS

113 FDF Dossiers

76 FDA Orange Book

23 Europe

13 Canada

1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - 1.18GM/100ML (11.8MG/ML);1.12GM/100ML (11.2MG/ML)

SOLUTION;INTRAVENOUS - 1.18GM/5ML (236MG/ML);1.12GM/5ML (224MG/ML)

SOLUTION;INTRAVENOUS - 1.18GM/250ML (4.72MG/ML);1.12GM/250ML (4.48MG/ML)

SOLUTION;INTRAVENOUS - 11.8GM/50ML (236MG/ML);11.2GM/50ML (224MG/ML)

SOLUTION;INTRAVENOUS - 3.54GM/15ML (236MG/ML);3.36GM/15ML (224MG/ML)

RELATED EXCIPIENT COMPANIES

2 EUROAPI

2 Evonik

7 Rochem International Inc

19 SPI Pharma

6 DKSH

4 Boai NKY Pharmaceuticals Ltd

7 Gangwal Healthcare

7 Nanjing Well Pharmaceutical

3 Pfanstiehl

13 Kirsch Pharma

1 ACG Worldwide

15 Actylis

1 Aeon Procare

8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

1 Avesta Pharma

28 BASF

1 Bioplus Life Sciences

3 CD Formulation

2 Clariant

10 Corel Pharma Chem

6 DFE Pharma

2 Esteem Industries

3 Finar

9 Gangwal Chemicals

4 Ideal Cures

5 Ingredion Pharma Solutions

20 Kerry

3 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

17 Microlex e.U

1 Nanjing Bold Chemical

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

2 Novo Excipients

3 Pharmatrans-Sanaq

10 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

39 Roquette

8 Seppic

7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

2 Shijiazhuang Huaxu Pharmaceutical

11 Sigachi Industries

4 Silverline Chemicals

1 Symrise

2 The Dow Chemical Company

1 Ulanqab Kema New Material

4 Vasa Pharmachem